Send Story by Email

FDA Approves Remdesivir for Babies and Young Children to Treat COVID-19

04-29-2022 • Summary by Jw Williams

The US Food and Drug Administration announced that full approval will be granted to Remdesivir, a COVID-19 drug to treat babies and children aged 28 days and older.

Your First Name

Your Last Name

Your Email Address

Enter one or more email addresses below. Separate multiple addresses with a semicolon (;) or a new line. Maximum 10 email addresses at one time.

To Email Address(es)

Personal Note

Also Send Daily Headlines Newsletter

Freedoms Phoenix

Online Magazine

Join-Us

Newspaper

Phone Apps

Declare Your Independence with Ernest Hancock

REAL TIME SPOT PRICES

Live Broadcast

Declare Your Independence

MENU

Send Story by Email

FDA Approves Remdesivir for Babies and Young Children to Treat COVID-19

FreedomsPhoenix.com